Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022345

Expand all

POTIGA (EZOGABINE)
50MG
Marketing Status: Discontinued

Active Ingredient: EZOGABINE
Proprietary Name: POTIGA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022345
Product Number: 001
Approval Date: Jun 10, 2011
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information

POTIGA (EZOGABINE)
200MG
Marketing Status: Discontinued

Active Ingredient: EZOGABINE
Proprietary Name: POTIGA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022345
Product Number: 002
Approval Date: Jun 10, 2011
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information

POTIGA (EZOGABINE)
300MG
Marketing Status: Discontinued

Active Ingredient: EZOGABINE
Proprietary Name: POTIGA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022345
Product Number: 003
Approval Date: Jun 10, 2011
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information

POTIGA (EZOGABINE)
400MG
Marketing Status: Discontinued

Active Ingredient: EZOGABINE
Proprietary Name: POTIGA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 400MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022345
Product Number: 004
Approval Date: Jun 10, 2011
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information